Ricciardi Lisa
CEO & President
Ricciardi Lisa has filed 4 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Apr 20, 2026.
On the most recent filing, Ricciardi Lisa is listed as CEO & President at COGNITION THERAPEUTICS INC. Inside the rolling window, Ricciardi Lisa reported 1 open-market purchase totaling $10K in CGTX and no open-market sales.
Companies traded
Other insiders at CGTX
Insider Buying
$10K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Ricciardi Lisa made?
Ricciardi Lisa has filed 4 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does Ricciardi Lisa trade?
Ricciardi Lisa has filed SEC Form 4 disclosures for 1 company, including CGTX.
When was Ricciardi Lisa's most recent SEC Form 4 filing?
Ricciardi Lisa's most recent SEC Form 4 filing on Tracefour is dated Apr 20, 2026.
What is Ricciardi Lisa's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Ricciardi Lisa is listed as CEO & President.
What is Ricciardi Lisa's total buy and sell value in the current window?
Inside the rolling retention window, Ricciardi Lisa bought $10K and sold $0 based on SEC Form 4 filings.
What was Ricciardi Lisa's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 9,175 CGTX shares on 2026-04-16, worth $10K, per SEC Form 4 filings.